Ex vivo gene transfer into hepatocytes

Area of Science:

• Hepatocyte biology
• Gene therapy
• Molecular biology

Background:

• Ex vivo gene transfer into hepatocytes is crucial for gene therapy and cell transplantation.
• Applications include therapeutic gene delivery, cell identification, conditional immortalization, and immune tolerance induction.

Purpose of the Study:

• To review methods for ex vivo gene transfer into hepatocytes.
• To highlight the potential of various gene delivery systems for therapeutic applications.

Main Methods:

• Non-viral gene transfer using transposon systems (e.g., Sleeping Beauty), cationic liposomes, Nucleofection, and hepatocyte-targeted proteoliposomes.
• Viral gene transfer employing adenoviral vectors (episomal) and retroviral vectors, including lentiviruses (genome integration).
• Enhancement techniques like Magnetofection for lentiviral vectors.

Main Results:

• Successful gene transfer achieved using both non-viral and viral methods in cultured hepatocytes.
• Transposon systems facilitate transgene integration, while viral vectors enable episomal or integrated gene delivery.
• Lentiviral vectors demonstrated efficacy in both attached and suspended hepatocytes, with improved transduction via Magnetofection.

Conclusions:

• Ex vivo hepatocyte gene transfer is a versatile platform for diverse therapeutic strategies.
• A range of non-viral and viral delivery systems are available, each with specific advantages for transgene integration and expression.
• Advanced techniques continue to improve the efficiency and applicability of hepatocyte gene transfer in clinical settings.